Skip to content
Washington University School of Medicine in St. Louis

Hospital Medicine Virtual Journal Club

Menu
  • About
  • Archives
  • FAQs
  • How to Access Full-text Articles
  • How to Use
  • Privacy Policy and Terms of Use

Category: lancet haematol

Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study.

lancet haematol • April 30, 2018

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.

lancet haematol • October 11, 2017

Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.

lancet haematol • April 16, 2017

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.

lancet haematol • February 22, 2017

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.

lancet haematol • August 30, 2016

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.

lancet haematol • August 2, 2016

Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis.

lancet haematol • January 15, 2016

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.

lancet haematol • January 15, 2016

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.

lancet haematol • December 22, 2015

Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.

lancet haematol • December 22, 2015

Follow Us!

Follow Us on FacebookFollow Us on TwitterFollow Us on Instagram

Journal Club via Email

Links

  • WU School of Medicine
  • Dept. of Medicine
  • Division of Hospital Medicine
  • Becker Medical Library
  • Society of Hospital Medicine
  • Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM, FACP
Mastodon

Powered by
PubMed

©2023 Washington University in St. Louis